Exisulind

WikiDoc Resources for Exisulind
Articles
Most recent articles on Exisulind Most cited articles on Exisulind Review articles on Exisulind Articles on Exisulind in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Exisulind Images of Exisulind Photos of Exisulind Podcasts & MP3s on Exisulind Videos on Exisulind
Evidence Based Medicine
Cochrane Collaboration on Exisulind Bandolier on Exisulind TRIP on Exisulind
Clinical Trials
Ongoing Trials on Exisulind at Clinical Trials.gov Trial results on Exisulind Clinical Trials on Exisulind at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Exisulind NICE Guidance on Exisulind NHS PRODIGY Guidance FDA on Exisulind CDC on Exisulind
Books
Books on Exisulind
News
Exisulind in the news Be alerted to news on Exisulind News trends on Exisulind
Commentary
Blogs on Exisulind
Definitions
Definitions of Exisulind
Patient Resources / Community
Patient resources on Exisulind Discussion groups on Exisulind Patient Handouts on Exisulind Directions to Hospitals Treating Exisulind Risk calculators and risk factors for Exisulind
Healthcare Provider Resources
Symptoms of Exisulind Causes & Risk Factors for Exisulind Diagnostic studies for Exisulind Treatment of Exisulind
Continuing Medical Education (CME)
CME Programs on Exisulind
International
Exisulind en Espanol Exisulind en Francais
Business
Exisulind in the Marketplace Patents on Exisulind
Experimental / Informatics
List of terms related to Exisulind

Overview

Exisulind is a drug used to treat cancer. It acts by inhibiting the enzyme cyclic guanosine monophosphate phosphodiesterase. Tademark by OSI Pharmaceuticals is Aptosyn. Template:WH Template:WS